advertisement
Abstract #10683 Published in IGR 6-2
Intermediate-term results of Baerveldt tube shunt surgery with mitomycin C use
Irak I; Moster MR; Fontanarosa JOphthalmic Surgery Lasers and Imaging 2004; 35: 189-96
BACKGROUND AND OBJECTIVE: To study the intermediate-term results of the Baerveldt glaucoma drainage device with adjunctive use of intraoperative mitomycin C. PATIENTS AND METHODS: Charts of 243 consecutive patients with advanced glaucoma who had undergone tube shunt surgery between 1992 and 1999 were retrospectively analyzed. A total of 64 patients were eligible for the study. Patients were observed for a mean of 34.3 ± 21 months. Kaplan-Meier survival analysis was used to determine intermediate-term success. RESULTS: The mean preoperative intraocular pressure (IOP) was 34.4 mmHg and the 1-year postoperative IOP was 16.6 mmHg. The mean percent IOP reduction after surgery was 51.7%, 53.2%, and 51.4% at 1, 2, and 5 years, respectively. Kaplan-Meier analysis showed a 77% success rate at 1 year, 66% at 2 years, and 59% at 5 years. The most common complication was choroidal detachment (18.8%). CONCLUSION: The use of mitomycin C with Baerveldt implantation showed IOP control equivalent to that without mitomycin C at intermediate follow-up.
Glaucoma Service, Wills Eye Hospital/Jefferson Medical College, Philadelphia, PA 19107, USA.
Classification:
12.8.2 With tube implant or other drainage devices (Part of: 12 Surgical treatment > 12.8 Filtering surgery)
12.8.10 Woundhealing antifibrosis (Part of: 12 Surgical treatment > 12.8 Filtering surgery)
